SCHEMBL5333748

SCHEMBL5333748

NCCCC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)Nc1nc(-c2ccccc2)cs1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 12/20 0.57
HDAC1 Q13547 12/20 0.57
HDAC6 Q9UBN7 11/20 0.57
HDAC2 Q92769 11/20 0.57
HDAC3 O15379 10/20 0.57
HDAC7 Q8WUI4 10/20 0.57
HDAC10 Q969S8 10/20 0.57
HDAC11 Q96DB2 10/20 0.57
HDAC8 Q9BY41 10/20 0.57
HDAC9 Q9UKV0 10/20 0.57
HDAC5 Q9UQL6 10/20 0.57
MEF2D Q14814 2/20 0.53
EP300 Q09472 1/20 0.51
TLR2 O60603 2/20 0.51
MDM4 O15151 1/20 0.48
TP53 P04637 1/20 0.48
MDM2 Q00987 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5333743 1.00 HDAC4 (0.57) HDAC4HDAC1HDAC6HDAC2HDAC3
SCHEMBL26614628 0.86 HDAC1 (0.56) HDAC4HDAC1HDAC6HDAC2HDAC3
SCHEMBL5457700 0.86 HDAC1 (0.56) HDAC4HDAC1HDAC6HDAC2HDAC3
SCHEMBL21241896 0.84 HDAC6 (0.52) HDAC4HDAC1HDAC6HDAC2HDAC3
SCHEMBL3952816 0.84 HDAC4 (0.54) HDAC4HDAC1HDAC6HDAC2HDAC3
SCHEMBL8117831 0.84 HDAC6 (0.77) HDAC4HDAC1HDAC6HDAC2HDAC3
SCHEMBL14596249 0.83 TLR2 (0.59) TLR2MDM4TP53MDM2
SCHEMBL14111048 0.83 TLR2 (0.59) TLR2MDM4TP53MDM2
SCHEMBL26546948 0.83 HDAC6 (0.60) HDAC4HDAC1HDAC6HDAC2HDAC3
SCHEMBL8119450 0.83 HDAC6 (0.76) HDAC4HDAC1HDAC6HDAC2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007143822-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-21 WO disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 HDAC4 12/4885HDAC1 1/4885HDAC6 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.